GMP Insiders - Your trusted source for GMP compliance!

Subscribe

GMP Insiders logo
GMP Insiders logo
GMP Insiders logo
Picture of GMP Insiders Expert Team

GMP Insiders Expert Team

The GMP Insiders Expert Team is a group of seasoned professionals specializing in quality assurance, regulatory compliance, and operational innovation in pharmaceutical and biotech manufacturing. United by a passion for advancing Good Manufacturing Practices, they transform complex compliance challenges into clear, actionable strategies that drive operational excellence.

Author social media channels:

Author's Latest Publications

Moist heat sterilization using an autoclave for pharmaceutical and GMP applications.

What Is Moist Heat Sterilization?

What moist heat sterilization really means in GMP: mechanisms, cycle types, limitations, and regulatory expectations beyond 121 °C for 15...
Read more >>
EU GMP Annex 11 versus FDA 21 CFR Part 11 comparison for computerized systems and electronic records

Annex 11 vs 21 CFR Part 11: Comparison and GMP Requirements

Comparison of Annex 11 and 21 CFR Part 11, with practical takeaways on validation, governance, risk management, audit trails, electronic...
Read more >>
Types of Batch Records Used in the Pharmaceutical Industry

Types of Batch Records Used in the Pharmaceutical Industry

A clear guide to the main pharma batch records (MBR, BMR, BPaR, QC logs, EBRs), what each proves, and the...
Read more >>
Good Documentation Practice (GDocP) in GMP, highlighting the role of structured, controlled documentation in ensuring data integrity, regulatory compliance, and trustworthy pharmaceutical records.

Good Documentation Practice (GDocP) in Pharma

A practical guide to Good Documentation Practice (GDocP) in pharma, covering ALCOA++, data integrity, inspections, electronic records, and compliance controls....
Read more >>
FY 2025 FDA inspection observations visual – quality audit and compliance review with executive hands analyzing reports and regulatory data.

FY 2025 FDA Inspection Observations: Quality Maturity in Drug and Medical Device Manufacturing

FY 2025 FDA inspection observations reveal recurring weaknesses in drug and medical device manufacturing, highlighting quality maturity, governance, and lifecycle...
Read more >>
fda-warning-letter-analysis

FDA Warning Letter Analysis: Catalent Indiana, LLC

This FDA Warning Letter analysis examines how weak investigations, ineffective contamination control strategies, and batch-release-driven decision making allowed contamination risks...
Read more >>
Software validation vs verification in GMP computerized systems with lifecycle and compliance focus

Software Validation vs Verification in GMP

Software validation vs verification explained under EU GMP Annex 11, FDA 21 CFR Part 11, and GAMP 5, with practical...
Read more >>
Featured graphic comparing terminal sterilization and aseptic processing in GMP manufacturing, with laboratory autoclave and sterile bottles.

Terminal Sterilization vs Aseptic Processing: Key Differences

Terminal sterilization vs aseptic processing explained. Compare sterility assurance levels, risks, validation expectations, and GMP regulatory guidance....
Read more >>
fda-warning-letter-analysis

FDA Warning Letter Issued to Rhyz Analytical Labs – November 12, 2025

FDA Warning Letter to Rhyz Analytical Labs cites CGMP failures in OOS investigations and Quality Unit oversight at a contract...
Read more >>
Featured image titled ‘What Is GAMP 5?’ showing a laboratory software engineer working at a computer with code on screen, used for an article explaining GAMP 5 risk-based validation, software categories, and regulatory alignment.

GAMP 5 in CSV: Definition, Categories, and Pharma Guidelines

Understand GAMP 5 with simple guidance on lifecycle control, validation deliverables, software categories, and risk-based decision-making in GMP environments....
Read more >>
GMP Insiders LOGO Inverted

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!